• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Henryschein Dental Company (NQ: HSIC )

    70.23 -0.41 (-0.58%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 31, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Henryschein Dental Company

    < Previous 1 2 3 4 Next >
    Where Henry Schein Stands With Analysts
    Via Benzinga
    Forecasting The Future: 5 Analyst Projections For Henry Schein
    Via Benzinga
    HSIC Stock Earnings: Henry Schein Meets EPS, Misses Revenue for Q2 2024
    HSIC stock results show that Henry Schein met analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
    Via InvestorPlace
    Dental Equipment Distributor Henry Schein Reports Mixed Q2 Earnings, Cuts Guidance And Warns Slower Recovery From Cyberattack
    Henry Schein Q2 adjusted EPS fell 6.1% to $1.23, beating the $1.22 consensus. Sales grew 1% to $3.10 billion, missing the $3.27B forecast. The company announced a restructuring plan for $75-$100... 
    Via Benzinga
    NVIDIA To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Monday
    Via Benzinga
    Analyst Expectations For Henry Schein's Future
    Via Benzinga
    Breaking Down Henry Schein: 4 Analysts Share Their Views
    Via Benzinga
    NASDAQ:HSIC: good value for what you're paying.
    HENRY SCHEIN INC (NASDAQ:HSIC) appears to be flying under the radar despite its strong fundamentals. 
    Via Chartmill
    Looking Into Henry Schein's Recent Short Interest
    Via Benzinga
    You’ve Been Warned! 3 S&P 500 Stocks to Buy Now or Regret Forever.
    The Magnificent Seven aren't the only game in town. These less discovered S&P 500 stocks to buy will deliver tremendous results going forward. 
    Via InvestorPlace
    Topics Stocks
    Exposures US Equities
    Peering Into Henry Schein's Recent Short Interest
    Via Benzinga
    Looking Into Henry Schein's Recent Short Interest
    Via Benzinga
    Expert Outlook: Henry Schein Through The Eyes Of 7 Analysts
    Via Benzinga
    Dental Supplies Distributor Henry Schein's Tech Segment Provides Some Stability In Challenging Macro Times: Analyst
    Henry Schein reports Q1 adjusted EPS at $1.10, down 9% Y/Y, with sales at $3.17 billion, up 3.7%. Guidance projects 2024 sales growth at 8%-10%, reaffirming adjusted EPS guidance of $5.00-$5.16.... 
    Via Benzinga
    HSIC Stock Earnings: Henry Schein Beats EPS, Misses Revenue for Q1 2024
    HSIC stock results show that Henry Schein beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
    Via InvestorPlace
    (HSIC) - Analyzing Henry Schein's Short Interest
    Via Benzinga
    5 Analysts Assess Henry Schein: What You Need To Know
    Via Benzinga
    Earnings Scheduled For February 27, 2024
    Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on revenue of $100.49 million. 
    Via Benzinga
    Henry Schein Earnings Preview
    Via Benzinga
    Jack Daniels Parent Company, EA, Cognizant Among 6 Stocks That Shine When Nvidia Slips: Analysis
    The analysis screened S&P 500 stocks that show an inverse correlation to Nvidia over a month and year period, following Nvidia's stock falling into correction territory for the second time this month. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Cybersecurity Incident Casts Shadow On Henry Schein's Q4 Performance, Analysts Optimistic On Dental Sector
    Henry Schein reports fourth quarter 2023 sales at $3.02 billion. Despite cybersecurity challenges, William Blair is optimistic. 
    Via Benzinga
    Looking Into Henry Schein's Recent Short Interest
    Via Benzinga
    What Vitamins Did For Healthy Living, Stemtech Corporation (OTCQB: STEK) Says It Is Doing For Anti-Aging With Stem Cell Nutrition
    Vitamins may not be a miracle cure, but combined with exercise and a healthy diet, they have the potential to greatly improve health and wellness. It’s no wonder vitamin supplements are a multi-billion... 
    Via Benzinga
    Behind Al Gore's $19 Billion Investment Firm and How He Made Millions in Apple Stock
    Is Al Gore one of the best investors of the century? He should be in the conversation. 
    Via The Motley Fool
    What 8 Analyst Ratings Have To Say About Henry Schein
    Via Benzinga
    What 5 Analyst Ratings Have To Say About Henry Schein
    Via Benzinga
    These Analysts Slash Their Forecasts On Henry Schein After Q3 Results
    Henry Schein Inc (NASDAQ: HSIC) posted downbeat sales results for its third quarter on Monday. 
    Via Benzinga
    Fear Continues To Grip Markets Ahead Of Inflation Data
    The CNN Money Fear and Greed index showed some easing in the overall fear level, with the index remaining in the "Fear" zone on Monday. U.S. stocks closed mixed on Monday, ahead of the release of key... 
    Via Benzinga
    Topics Economy
    Exposures Interest Rates
    Why Is Dental Supplier Henry Schein Stock Trading Higher Today?
    Henry Schein Inc (NASDAQ: HSIC) reported Q3 FY23 sales of $3.16 billion, slightly missing the  
    Via Benzinga
    Topics Supply Chain
    Exposures Supply Chain
    Monday.Com Reports Q3 Beat, Joins Fortrea Holdings, Henry Schein And Other Big Stocks Moving Higher On Monday
    U.S. stocks traded lower, with the Dow Jones falling around 40 points on Monday. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    < Previous 1 2 3 4 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.